聚L-乳酸/二氧化硅纳米复合材料及其表面诱导生成类骨磷灰石的制备

为改善纳米SiO2粒子在聚L-乳酸基体中的分散性, 将乳酸齐聚物接枝到纳米SiO2粒子表面, 通过IR, 29Si MAS NMR和TGA对改性SiO2进行表征. 以聚L-乳酸(PLLA)为基体, 加入乳酸齐聚物接枝改性的二氧化硅(g-SiO2)粒子, 采用溶液浇铸法制备PLLA/g-SiO2纳米复合材料, 测试其在模拟体液(SBF)中的生物活性. 通过XRD, IR, SEM和EDS表征手段, 考察材料表面类骨磷灰石形成能力. 结果表明, 乳酸齐聚物成功地接枝到SiO2表面, 当反应36 h时, g-SiO2接枝率最大(9.22%). 随着g-SiO2含量增加和浸泡时间的延长, 材料表面最初形成的无定形沉积物矿化成碳酸羟基磷灰石(Carbonated hydroxyapatite, CHA), 钙磷比为1.72, 类似于人骨无机质, 表明g-SiO2的引入能明显加速复合材料表面CHA沉积, 该复合材料有望成为骨修复填充材料和组织工程支架材料.     

Flow—injection Chemiluminescence Determination of Reserpine in Medicine and Biological Fluids with Controlled—Reagent—Release Technology

A sensitive and rapid chemiluminescence(CL) flow injection with controlled-reagent-release technology for the determination of reserpine was proposed.The Cl reagents,luminol and dichromate,uses in this sensor,were all immobilized on anion-exchange resin.Through injection of 100μl of water,the reagents on the anion-ex-change resin column were eluted and in the presence of reserpine ,the CL intensity was decreased,by which reserpine could be sensed.Reserpine was quantified by measuring the decrement of CL intensity,which was observed linear with the logrithm of reserpine concentration in the rage of 1.0-500.0ng/mL,and the limit of detection was 0.4ng/mL(3σ)with a relative standard deviation of less than 3.0?The proposed procedure was applied in the assay of reserpine in pharmaceutical preparation and biological fhuids without any pre-treatment process and with sampling frequencies of 72 times per hour.     

国产吸附树脂在体液毒物分析中的应用：Ⅰ.对胺类毒物的吸附

简便快速的液固分离富集技术已在分析实验室广泛采用。本文报道了七种国产大孔吸附树脂对四种胺类毒物的吸附性能,研究了最佳吸附及解吸条件,经与进口的Amberlite XAD-2树脂和Sep pak C_(18)柱比较,国产的X-5树脂对人尿中较低浓度的阿托品等胺类毒物有良好的吸附性能。     

模拟体液法制备纳米级羟基磷灰石

用模拟体液法制备纳米羟基磷灰石(hydroxyapatite,HAP or HA)粉体。研究了反应温度、反应浓度和反应时间对合成的影响。结果发现,制备纳米级羟基磷灰石的最佳工艺条件为:反应温度60℃,浓度为15倍的模拟体液(simulate body fluid,SBF),反应时间为10h。在此工艺条件下制备的羟基磷灰石粉体的微观形貌为球形颗粒,平均颗粒直径为30 nm。     

体液中-叶萩碱检测方法的研究

本文报道了用气相色谱(GC)及气相色谱-质谱联用(GC/MS)检出人体液中一叶萩碱的方法.尿样经碱化后用乙醚直接萃取,回收率为72.1％;血浆样品用Sep-pak小柱提取,回收率为 43.9％,GC/MS的检测限为 20ng.方法快速、简便、准确.     

Determination of captopril in pharmaceutical preparation and biological fluids using two- and three-way chemometrics methods

Spectrophotometric method has been developed for the direct quantitative determination of captopril in pharmaceuticalpreparation and biological fluids(human plasma and urine)samples.The method was accomplished based on parallel factoranalysis(PARAFAC)and partial least squares(PLS).The study was carried out in the pH range from 2.0 to 12.8 and with aconcentration from 0.70 to 61.50 μg mL~(-1)of captopril.Multivariate calibration models such as PLS at various pH and PARAFACwere elaborated from ultraviolet spectra deconvolution and captopril determination.The best models for this system were obtainedwith PARAFAC and PLS at pH 2.0.The applications of the method for determination of real samples were evaluated by analysis ofcaptopril in pharmaceutical preparations and biological fluids with satisfactory results.The accuracy of the method,evaluatedthrough the RMSEP,was 0.5801 for captopril with best calibration curve by PARAFAC and 0.6168 for captopril with PLS at pH 2.0model.     

CaO-P2O5-SiO2系统溶胶-凝胶生物活性多孔材料在SBF中的性能研究

利用溶胶-凝胶生物活性材料粉末二次烧结工艺,制备了CaO-P2O5-SiO2系统溶胶-凝胶生物活性多孔材料,并利用体外实验(in vitro)方法和XRD,SEM及FTIR技术研究了此烧结材料的显微形貌、晶相、生物活性和可降解性能.结果表明,经800℃烧结5 min后,有少量硅磷酸钙[Ca5(PO4)2SiO4,5CPS]析出,在模拟体液(SBF)中浸泡,随着时间的增长,材料表面最初形成的无定形钙磷化合物矿化成碳酸羟基磷灰石(HCA)纳米团簇,并逐渐相互融合形成HCA覆盖层;HCA只在烧结体的玻璃相(SG相)表面生成,在5CPS微晶相表面未发现HCA,该材料在37℃恒温的SBF溶液中具有较高的生物活性和可降解性能.     

光系统Ⅱ反应中心内组氨酸参与给体端次级电子转移反应的人工模拟ESR研究

对高等植物光系统皿(PS)反应中心的超分子模型化合物光诱导电子转移(PET)过程的研究主要集中在原初电子给体P。s。与其还原侧电子受体间的电子转移反应[‘’u．近年来,随着人们对高等植     

体液的在线样品前处理技术及其小分子化合物的液相色谱-质谱分析

在线样品前处理液相色谱-质谱联用技术为体液中痕量小分子化合物提供了高灵敏度、高选择性和高通量的分析方法。该文以在线固相萃取柱为主线,总结了不同种类富集柱的特点及其近5年来在相关领域的应用,并简要介绍了在线液相色谱-质谱分析的流路系统。